Clinical trial
The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome
NCT05465135 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2022
- Completion date
- April 23, 2023
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.